共 26 条
[1]
Chan M., World Now at the Start of 2009 Influenza Pandemic, (2009)
[2]
Zivkovic Gojovic M., Sander B., Fisman D., Krahn M.D., Bauch C.T., Modelling mitigation strategies for pandemic (H1N1) 2009, CMAJ, Early Release Published at
[3]
Nuno M.C.G., Gumel A.B., Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: Scenarios for the US, UK and Netherlands, J R Soc Interface, 4, pp. 505-521, (2007)
[4]
Sypsa V., Pavlopoulou I., Hatzakis A., Use of an inactivated vaccine in mitigating pandemic influenza A(H1N1) spread: A modelling study to assess the impact of vaccination timing and prioritisation strategies, Euro Surveill, 14, 41, (2009)
[5]
Maurer J., Et al., Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: Evidence from a nationally representative survey of U.S. adults, Vaccine, 27, 42, pp. 5732-4, (2009)
[6]
Lau J.T.F., Yeung N.C.Y., Choi K.C., Cheng M.Y.M., Tsui H.Y., Griffiths S., Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: Population based cross sectional survey, BMJ, 2009, 339, (2009)
[7]
Seale H., McLaws M.L., Heywood A.E., Ward K.F., Lowbridge C.P., Van D., Gralton J., MacIntyre C.R., The community's attitude towards swine flu and pandemic influenza, The Medical Journal of Australia, 191, 5, pp. 267-269, (2009)
[8]
Lagarde F., Summary of Public Opinion on Immunization in Canada, (2005)
[9]
Brewer N.T., Fazekas K.I., Predictors of HPV vaccine acceptability: A theory-informed, systematic review, Preventive Medicine, 45, 2-3, pp. 107-114, (2007)
[10]
Zimet G.D., Liddon N., Rosenthal S.L., Lazcano-Ponce E., Allen B., Chapter 24: Psychosocial aspects of vaccine acceptability, Vaccine, 24, SUPPL. 3, (2006)